Abivax (ABVX) Other Operating Expenses (2024 - 2026)

Abivax's Other Operating Expenses history runs 3 years deep, the most recent figure standing at -$2.0 million for Q1 2026.

• In Q1 2026, Other Operating Expenses fell 126.35% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at $5.0 million (down 33.42% YoY), while the FY2025 annual figure was $6.0 million, down 4.97% from the prior year.
• Other Operating Expenses was -$2.0 million for Q1 2026 at Abivax, down from $10.0 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $11.8 million in Q4 2024 to a low of -$2.4 million in Q2 2024.
• Historically, Other Operating Expenses has averaged $1.2 million across 3 years, with a median of -$936781.2 in 2024.
• Biggest YoY gain for Other Operating Expenses was 68.53% in 2025; the steepest drop was 129.5% in 2025.
• A 3-year view of Other Operating Expenses shows it stood at $11.8 million in 2024, then fell by 15.44% to $10.0 million in 2025, then slumped by 120.53% to -$2.0 million in 2026.
• The last three Other Operating Expenses figures came in at -$2.0 million (Q1 2026), $10.0 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.